Changes in Bone Marrow Adipose Tissue One Year After Roux-en-Y Gastric Bypass: A Prospective Cohort Study
- PMID: 31216081
- DOI: 10.1002/jbmr.3814
Changes in Bone Marrow Adipose Tissue One Year After Roux-en-Y Gastric Bypass: A Prospective Cohort Study
Abstract
Bone marrow adipose tissue (BMAT) has been postulated to mediate skeletal fragility in type 2 diabetes (T2D) and obesity. Roux-en-Y gastric bypass (RYGB) induces a substantial weight loss and resolution of comorbidities. However, the procedure induces increased bone turnover and fracture rates. No previous study has evaluated biopsy-measured BMAT fraction preoperatively and after RYGB. In this study, we aimed to investigate BMAT fraction of the hip in participants with and without T2D preoperatively and 1 year after RYGB and explore factors associated with BMAT change. Patients with morbid obesity scheduled for RYGB were examined preoperatively and 1 year after RYGB. Forty-four participants were included and preoperative examinations were possible in 35. Of these, 33 (94%) met for follow-up, 2 were excluded, and BMAT estimation was not possible in 1. Eighteen (60%) of the participants were females and 11 (37%) had T2D. Preoperative BMAT fraction was positively associated with glycosylated hemoglobin and negatively associated with areal bone mineral density (aBMD). After RYGB, BMAT fraction decreased from 40.4 ± 1.7% to 35.6 ± 12.8%, p = 0.042, or with mean percent change of 10.7% of preoperative BMAT fraction. Change in BMAT fraction was positively associated with change in body mass index (BMI) and total body fat. In females, we observed a mean percent reduction of 22.4 ± 19.6%, whereas in males BMAT increased with a mean percent of 6.8 ± 37.5%, p = 0.009. For males, changes in estradiol were associated with BMAT change; this was not observed for females. In participants with and without T2D, the mean percent BMAT reduction was 5.8 ± 36.9% and 13.5 ± 28.0%, respectively, p = 0.52. We conclude that a high BMAT seems to be associated with lower aBMD and poorer glycemic control in obese subjects. After RYGB, we observed a significant decrease in BMAT. The reduction in BMAT did not differ between participants with and without T2D, but appeared sex specific. © 2019 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals, Inc.
Keywords: BONE MARROW ADIPOSE TISSUE; BONE MARROW FAT; BONE MINERAL DENSITY; MORBID OBESITY; ROUX-EN-Y GASTRIC BYPASS; WEIGHT LOSS.
© 2019 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals, Inc.
Similar articles
-
The Impact of Interventional Weight Loss on Bone Marrow Adipose Tissue in People Living with Obesity and Its Connection to Bone Metabolism.Nutrients. 2023 Oct 29;15(21):4601. doi: 10.3390/nu15214601. Nutrients. 2023. PMID: 37960254 Free PMC article. Review.
-
Changes in bone quality after Roux-en-Y gastric bypass: A prospective cohort study in subjects with and without type 2 diabetes.Bone. 2020 Jan;130:115069. doi: 10.1016/j.bone.2019.115069. Epub 2019 Oct 5. Bone. 2020. PMID: 31593823
-
Bone metabolism, bone mineral density and low-energy fractures 10 years after Roux-en-Y gastric bypass.Bone. 2019 Oct;127:436-445. doi: 10.1016/j.bone.2019.07.014. Epub 2019 Jul 16. Bone. 2019. PMID: 31323430
-
Effects of Roux-en-Y gastric bypass and sleeve gastrectomy on bone mineral density and marrow adipose tissue.Bone. 2017 Feb;95:85-90. doi: 10.1016/j.bone.2016.11.014. Epub 2016 Nov 15. Bone. 2017. PMID: 27871812 Free PMC article.
-
Randomized Controlled Trial of One Anastomosis Gastric Bypass Versus Roux-En-Y Gastric Bypass for Obesity: Comparison of the YOMEGA and Taiwan Studies.Obes Surg. 2019 Sep;29(9):3047-3053. doi: 10.1007/s11695-019-04065-2. Obes Surg. 2019. PMID: 31290104 Review.
Cited by
-
The Impact of Interventional Weight Loss on Bone Marrow Adipose Tissue in People Living with Obesity and Its Connection to Bone Metabolism.Nutrients. 2023 Oct 29;15(21):4601. doi: 10.3390/nu15214601. Nutrients. 2023. PMID: 37960254 Free PMC article. Review.
-
New Insights into Calorie Restriction Induced Bone Loss.Endocrinol Metab (Seoul). 2023 Apr;38(2):203-213. doi: 10.3803/EnM.2023.1673. Epub 2023 Apr 27. Endocrinol Metab (Seoul). 2023. PMID: 37150516 Free PMC article.
-
Bone Health after Bariatric Surgery: Consequences, Prevention, and Treatment.Adv Biomed Res. 2022 Oct 31;11:92. doi: 10.4103/abr.abr_182_21. eCollection 2022. Adv Biomed Res. 2022. PMID: 36518856 Free PMC article. Review.
-
Insulin and Body Mass Index Decrease Serum Soluble Leptin Receptor Levels in Humans.J Clin Endocrinol Metab. 2023 Apr 13;108(5):1110-1119. doi: 10.1210/clinem/dgac699. J Clin Endocrinol Metab. 2023. PMID: 36459457 Free PMC article.
-
Bone Response to Weight Loss Following Bariatric Surgery.Front Endocrinol (Lausanne). 2022 Jul 7;13:921353. doi: 10.3389/fendo.2022.921353. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35873004 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
